Can Researchers Use Dogs to Study Lymphoma?

North Carolina State University researchers are offering a new twist on testing and searching for genes involved in non-Hodgkin lymphoma. Due to the similar genetic makeup between dogs and humans, specialists at N.C. State have now begun to use canines as subjects for the purposes of learning more about lymphoma.

The research, which was published in the journal Leukemia and Lymphoma, notes the genetic information from dogs with non-Hodgkin lymphoma, and then proceeds to “recode” the genomes of the dogs as if they were human.

“This is the first time that we were able to compare this information from dogs with lymphoma directly with existing data from human patients diagnosed with the equivalent cancer and using the same technique,” said Dr. Rachael Thomas, research assistant professor of molecular biomedical sciences at NC State and lead author of the paper.

Dr. Matthew Breen, professor of genomics at North Carolina State had this to say on the research:

“In essence, we stripped the background noise from the human data,” Breen says. “Lymphoma genomics is a lot more complex in human patients than in dog patients. This study tells us that while both humans? and dogs? have comparable disease at the clinical and cellular level, the genetic changes associated with the same cancers are much less complex in the dog.

“This suggests that maybe there is a lot of genetic noise in the human cancers that are not essential components of the process. While human studies have been looking in numerous places in the genome, the dog data indicate we need to focus on what’s shared, and these are very few regions.”

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap